Other research suggests the drugs might increase the risk of acute kidney injury (StatPearls) and gastrointestinal disorders (Nature Medicine)
Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR
Understanding your individual predispositionsincluding genetic factors that influence GLP-1 receptor sensitivity and glucose metabolismcan help you and your healthcare provider develop a more informed, personalized treatment plan that optimizes tolerability and efficacy
Some people may be more sensitive to medications, which could increase their chances of having side effects like leg cramps
Semaglutide Semaglutide is a GLP-1 receptor agonist, a synthetic analog of glucagon-like peptide-1, an intestinal hormone released after eating
A request for additional safety data would push it later